Novartis launch renewed attack on India’s right to produce affordable medicines
Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
The hearing, in the Indian Supreme Court, comes six years after Novartis first lost its battle to stop India producing copies of anti-cancer medicine Glivec (or Gleevec in the USA), which cost as much as ten times less than the original. Now Novartis are trying to find a loophole that would delay the ability of Indian drug companies to produce cheaper medicines, which supply most of the developing world.
The complicated legal wrangle over how India implements specific patent rules could set a groundbreaking legal precedent. If Novartis wins the case, similar claims for other medicines pending in court could go in favor of drug companies rather than the people whose lives depend on affordable generic drugs.
A source of life saving medication for millions
Oxfam Policy Advisor, Rohit Malpani, said: “Despite the fact Novartis has lost before, the company seems hell bent on pursuing this case and is determined to win a precedent, even though it could have a devastating impact on millions of people in developing countries.”
Generic medicines produced in India are among the cheapest in the world, and are the main source of life saving medication for millions. 90 per cent of medicines used to treat HIV/AIDS are currently made in India, but Novartis is putting India’s future as the ‘pharmacy of the developing world’ at stake. If the case is successful the result would mean delays in competition for all medicines produced, which would push prices up and have a significant impact on public health.
Malpani said: “This legal battle is a massive threat to those suffering from cancer, HIV and AIDS, diabetes and other diseases who are too poor to pay for medication.
Patients’ rights first
“India is setting a brave example for other developing countries, by standing firm under pressure from multinational drugs companies by putting patients’ rights first. The case must rule in favor of people not profits.”
Oxfam was part of a global campaign in 2006 calling on Novartis to put people before profits, which was backed by half a million people.
Blog: Robbing the poor to pay the rich – Novartis’ Christmas gift to itself! (Dec. 2008)
Video: Free medicines in Rajasthan, India (Feb. 2012)
Stop AIDS Campaign animation explains the 'patent pool'
Notes to Editors
In 2006, Novartis launched a legal battle challenging India's adoption of strict standards used to regulate patents on medicines. They argued that Section 3(d) of the recently amended Patents Act was ‘unconstitutional and violated international standards’ and wanted a 20-year patent monopoly on Glivec. The company is now challenging the established interpretation of Section (d) which requires a minor variation to previously invented medicines not be granted unless it significantly enhances the efficiency of the medicine in treating human illness or disease.
For more information, or to arrange an interview with an Oxfam spokesperson, please contact:
Sarah Dransfield, Oxfam press Officer: +44 (0)1865 472269, +44 (0)7767 085666, email@example.com, twitter: @SarahOxfam
In #Kenya, women own 1/2 of all small & medium enterprises, but lack comparable support/resources that men receive http://t.co/1JscJYHCZJ56 min 21 sec ago
Cameron: #G8 will 'knock down the wall of secrecy' on UK-linked #taxhavens. Will he make good? http://t.co/NjorjQpqAk @HuffPostUK1 hour 56 min ago
RT @OxfamEAfrica: "3 bombs fell in one of the camps. Refugees are fleeing." @Oxfam's Eddy Mbuyi on new #Goma fighting http://t.co/ygE0OnshU…2 hours 25 min ago
#Resilience is the new #globaldev buzzword. So how can we reduce #inequality & make people less vulnerable? http://t.co/HIRCgQ68eW #post20153 hours 2 min ago
We welcome @WorldBank support for removal of user fees, a major barrier to achieving Universal Health Coverage http://t.co/16paFMiifN #UHC3 hours 35 min ago
RT @louis_press: Report (in Arabic) on a great org helping Syrian refugees living in cemetery. On @AlArabiya w @ai_eman @Oxfam #syria http:…3 hours 59 min ago
4 hours 7 min ago
We're providing humanitarian aid in #Somalia via an innovative e-cash program http://t.co/AtzoQZzIsO #m4d4 hours 56 min ago
Ending #taxdodging in #India could feed all hungry people there. And much more. http://t.co/K6M6PlZ3ne5 hours 28 min ago
Tax lost offshore could end world poverty. TWICE OVER. http://t.co/kyaKgvtUcb 1/3 of #taxhavens under UK flag5 hours 52 min ago
[Share the infographic] When the #G8 meets in June, they must end #taxdodging for good http://t.co/WLRT1UZx4f #taxhavens #socmed8 hours 56 min ago
Scandalous: $18.5 trillion hidden in #taxhavens = $156bn lost in revenue which could help fight poverty http://t.co/8cc9k6F9d6 #taxdodging15 hours 39 min ago
Apple under scrutiny for #taxdodging, shows “unbelievable chutzpah.” http://t.co/XIL06OCU1A @nytimes #taxhavens22 hours 7 min ago
#Lille France-UK #Transparency Conference: Follow our @benphillips76 @LucLampriere @HannahStoddart. See also @pcanfin #landgrabs #taxdodging1 day 35 sec ago
Pls consider donating to our #SyriaCrisis Appeal. $10 covers basic needs items for 1 person for a month http://t.co/HtJ1uzYBpa1 day 12 min ago